MedTrace Logo

Use of AI Chatbots for Mental Health

NCT07658547 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-06-22

No results posted yet for this study

Summary

The goal of this observational study is to learn how patients with mental disorders use, perceive, and evaluate generative artificial intelligence (AI) chatbots for mental health-related purposes. The study aims to investigate usage patterns, expectations, experiences, perceived benefits, barriers, and concerns regarding AI chatbots among adults receiving psychiatric or psychotherapeutic treatment.

The main questions it aims to answer are:

* "How do patients with mental disorders use generative AI chatbots in the context of their mental health?"
* "What expectations, attitudes, and experiences do patients have regarding AI chatbots for mental health support?"

Participants will:

* Provide electronic informed consent before participation.
* Complete a one-time anonymous online survey lasting approximately 8 to 10 minutes.
* Answer questions about sociodemographic characteristics, psychiatric diagnoses, psychological distress, and digital device use.
* Report their expectations regarding AI chatbots for mental health support.
* Provide information about AI chatbot use, including frequency, duration, applications used, and purposes of use.
* Answer questions regarding satisfaction, trust, privacy concerns, perceived problems, and potential future integration of AI chatbots into mental health care.
* Optionally provide qualitative comments and suggestions in open-text fields.

There is no intervention, randomization, control group, or comparison arm in this study. The study follows a prospective cross-sectional mixed-methods design using quantitative survey data and qualitative free-text responses.

Conditions

  • Severe Mental Illness

Sponsors & Collaborators

  • Medizinische Hochschule Brandenburg Theodor Fontane

    lead OTHER

Principal Investigators

  • Schwarz · Medizinische Hochschule Brandenburg Theodor Fontane

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2026-08-31
Completion
2026-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07658547 on ClinicalTrials.gov